Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & Podcasts
Science & Medicine
GSK's CEO shakeup, Lilly's Alzheimer's uncertainty, and Valeant's latest disaster
Fierce editors discuss the pending retirement of GlaxoSmithKline CEO Andrew Witty, Eli Lilly's bold decision with a big Alzheimer's trial and Valeant Pharmaceuticals' rough week.
About This Episode
GSK's CEO shakeup, Lilly's Alzheimer's uncertainty, and Valeant's latest disaster is an episode from FierceBiotech Radio. Fierce editors discuss the pending retirement of GlaxoSmithKline CEO Andrew Witty, Eli Lilly's bold decision with a bi...
Podcast
This episode belongs to FierceBiotech Radio.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Mar 18, 2016, 28:41 long, audio available.
Related Episodes
Continue listening to more episodes from FierceBiotech Radio.
